Cargando…
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
Chemotherapeutic drugs cause DNA damage and kill cancer cells mainly by apoptosis. p53 mediates apoptosis after DNA damage. To explore the pathway of p53-dependent cell death, we investigated if p53-dependent apoptosis after DNA damage is mediated by the CD95 (APO-1/Fas) receptor/ligand system. We i...
Autores principales: | Müller, Martina, Wilder, Sylvia, Bannasch, Detlev, Israeli, David, Lehlbach, Katrin, Li-Weber, Min, Friedman, Scott L., Galle, Peter R., Stremmel, Wolfgang, Oren, Moshe, Krammer, Peter H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212386/ https://www.ncbi.nlm.nih.gov/pubmed/9841917 |
Ejemplares similares
-
Signaling through the Death Receptor CD95 (APO-1/FAS)
por: Peter, Marcus E.
Publicado: (2001) -
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
Publicado: (1995) -
Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression
por: Yamana, K, et al.
Publicado: (2005) -
Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase
Publicado: (1994) -
Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain
Publicado: (1996)